Prothrombin G20210a-related Thrombophilia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-24
Clinical Trial Update: A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation [Phase 1]
City Therapeutics' CITY-FXI is being studied in a Phase 1 single ascending dose trial to assess safety, tolerability, pharmacokinetics and p…